Advances in prostate and bladder cancer management: proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
[Amsterdam u.a.]
Elsevier
2006
|
| Schriftenreihe: | European urology
Supplements ; 5,3 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | S. 359 - 396 Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV021641996 | ||
| 003 | DE-604 | ||
| 005 | 20060711 | ||
| 007 | t | ||
| 008 | 060704s2006 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)75980811 | ||
| 035 | |a (DE-599)BVBBV021641996 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 245 | 1 | 0 | |a Advances in prostate and bladder cancer management |b proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 |c guest ed. C. C. Schulman ... |
| 264 | 1 | |a [Amsterdam u.a.] |b Elsevier |c 2006 | |
| 300 | |a S. 359 - 396 |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a European urology : Supplements |v 5,3 | |
| 650 | 4 | |a Bladder |x Cancer |x Treatment |v Congresses | |
| 650 | 4 | |a Prostate |x Cancer |x Treatment |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Schulman, Claude C. |e Sonstige |4 oth | |
| 711 | 2 | |a Symposium New Horizons in Urology |d 2005 |j Sonstige |0 (DE-588)6509921-7 |4 oth | |
| 830 | 0 | |a European urology |v Supplements ; 5,3 |w (DE-604)BV016427937 |9 5,3 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014856766&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014856766 | ||
Datensatz im Suchindex
| _version_ | 1804135444436221952 |
|---|---|
| adam_text | CONTENTS
introduction 359
C.C. Schulman, L Boccon Gibod
This supplement reports the proceedings of two meetings on urologic cancer control. The first meeting
Optimising testosterone control deals with improving hormonal therapy for prostate cancer. The
second meeting Urological cancer surgery evaluates open and laparoscopic surgery for prostate
and bladder cancer.
Hormone Therapy for Prostate Cancer: Guidelines versus Clinical Practice 362
A. Alcaraz, P. Teillac
This comparison of the EAU guidelines on prostate cancer with clinical practice patterns as expressed by
decisions taken by urologists demonstrates several gaps between the EAU guidelines and clinical practice.
Hoi mone Therapy: Improving Therapy Decisions and Monitoring 369
A.R. Zlotto, P. A. Abrahamsson, 8. Tombal. R. Serges, F. Debruyne
Measuring testosterone levels before and during therapy initiation might improve hormone therapy
decisions and monitoring. Eligard is an interesting luteinizing hormone releasing hormone (LHRH)
agonist because it is able to achieve and maintain testosterone levels 20 ng/dl.
Open versus Laparoscopic Radical Prostatectomy 377
G Janetschek, F Montorsi
Although each surgical method has its own advantages and disadvantages, the differences among
surgeons seem much more important than the differences between the surgical approaches. Once
surgeons overcome the procedure specific learning curve, the oncologic and functional outcomes
seem to be comparable.
Open versus Laparoscopic Radical Cystectomy 385
R Gaston. A. Heidenreich
Open radical cystectomy is considered as the gold standard to treat bladder cancer. In contrast,
laparoscopic cystectomy is still in its infancy, deals with many procedure related complications, and
requires a great deal of skill.
Keu Take Home Messages 395
C.C. Schulmon, L Boccon Gibod
Large variations in practice are seen in applying hormonal therapy for prostate cancer. In contrast to
older luteinizing hormone releasing hormone formulations, Eligard seems to achieve and maintain
testosterone levels similar to those obtained by surgical castration. Oncologic and functional outcomes
are more dependent on the surgeon than on the choice of the surgical procedure.
|
| adam_txt |
CONTENTS
introduction 359
C.C. Schulman, L Boccon Gibod
This supplement reports the proceedings of two meetings on urologic cancer control. The first meeting
"Optimising testosterone control" deals with improving hormonal therapy for prostate cancer. The
second meeting "Urological cancer surgery" evaluates open and laparoscopic surgery for prostate
and bladder cancer.
Hormone Therapy for Prostate Cancer: Guidelines versus Clinical Practice 362
A. Alcaraz, P. Teillac
This comparison of the EAU guidelines on prostate cancer with clinical practice patterns as expressed by
decisions taken by urologists demonstrates several gaps between the EAU guidelines and clinical practice.
Hoi mone Therapy: Improving Therapy Decisions and Monitoring 369
A.R. Zlotto, P. A. Abrahamsson, 8. Tombal. R. Serges, F. Debruyne
Measuring testosterone levels before and during therapy initiation might improve hormone therapy
decisions and monitoring. Eligard is an interesting luteinizing hormone releasing hormone (LHRH)
agonist because it is able to achieve and maintain testosterone levels 20 ng/dl.
Open versus Laparoscopic Radical Prostatectomy 377
G Janetschek, F Montorsi
Although each surgical method has its own advantages and disadvantages, the differences among
surgeons seem much more important than the differences between the surgical approaches. Once
surgeons overcome the procedure specific learning curve, the oncologic and functional outcomes
seem to be comparable.
Open versus Laparoscopic Radical Cystectomy 385
R Gaston. A. Heidenreich
Open radical cystectomy is considered as the gold standard to treat bladder cancer. In contrast,
laparoscopic cystectomy is still in its infancy, deals with many procedure related complications, and
requires a great deal of skill.
Keu Take Home Messages 395
C.C. Schulmon, L Boccon Gibod
Large variations in practice are seen in applying hormonal therapy for prostate cancer. In contrast to
older luteinizing hormone releasing hormone formulations, Eligard seems to achieve and maintain
testosterone levels similar to those obtained by surgical castration. Oncologic and functional outcomes
are more dependent on the surgeon than on the choice of the surgical procedure. |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV021641996 |
| ctrlnum | (OCoLC)75980811 (DE-599)BVBBV021641996 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01432nam a2200325 cb4500</leader><controlfield tag="001">BV021641996</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060711 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060704s2006 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)75980811</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021641996</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in prostate and bladder cancer management</subfield><subfield code="b">proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005</subfield><subfield code="c">guest ed. C. C. Schulman ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Amsterdam u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 359 - 396</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">European urology : Supplements</subfield><subfield code="v">5,3</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bladder</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schulman, Claude C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Symposium New Horizons in Urology</subfield><subfield code="d">2005</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)6509921-7</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">European urology</subfield><subfield code="v">Supplements ; 5,3</subfield><subfield code="w">(DE-604)BV016427937</subfield><subfield code="9">5,3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014856766&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014856766</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV021641996 |
| illustrated | Illustrated |
| index_date | 2024-07-02T15:00:16Z |
| indexdate | 2024-07-09T20:40:36Z |
| institution | BVB |
| institution_GND | (DE-588)6509921-7 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014856766 |
| oclc_num | 75980811 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | S. 359 - 396 Ill., graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Elsevier |
| record_format | marc |
| series | European urology |
| series2 | European urology : Supplements |
| spelling | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 guest ed. C. C. Schulman ... [Amsterdam u.a.] Elsevier 2006 S. 359 - 396 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier European urology : Supplements 5,3 Bladder Cancer Treatment Congresses Prostate Cancer Treatment Congresses (DE-588)1071861417 Konferenzschrift gnd-content Schulman, Claude C. Sonstige oth Symposium New Horizons in Urology 2005 Sonstige (DE-588)6509921-7 oth European urology Supplements ; 5,3 (DE-604)BV016427937 5,3 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014856766&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 European urology Bladder Cancer Treatment Congresses Prostate Cancer Treatment Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 |
| title_auth | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 |
| title_exact_search | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 |
| title_exact_search_txtP | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 |
| title_full | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 guest ed. C. C. Schulman ... |
| title_fullStr | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 guest ed. C. C. Schulman ... |
| title_full_unstemmed | Advances in prostate and bladder cancer management proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 guest ed. C. C. Schulman ... |
| title_short | Advances in prostate and bladder cancer management |
| title_sort | advances in prostate and bladder cancer management proceedings from the symposium new horizons in urology malta 29 30 october 2005 |
| title_sub | proceedings from the Symposium New Horizons in Urology, Malta, 29 - 30 October, 2005 |
| topic | Bladder Cancer Treatment Congresses Prostate Cancer Treatment Congresses |
| topic_facet | Bladder Cancer Treatment Congresses Prostate Cancer Treatment Congresses Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014856766&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV016427937 |
| work_keys_str_mv | AT schulmanclaudec advancesinprostateandbladdercancermanagementproceedingsfromthesymposiumnewhorizonsinurologymalta2930october2005 AT symposiumnewhorizonsinurology advancesinprostateandbladdercancermanagementproceedingsfromthesymposiumnewhorizonsinurologymalta2930october2005 |